The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Cell Signaling Technology sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Cell Signaling Technology Inc (CST) is a biological research and diagnostic products provider. It offers primary antibodies, antibody samplers, secondary antibodies, antibody conjugates, elisa kits, chip kits and reagents proteomic analysis products, cellular assay kits, WB and IP reagents, sirna, activators and inhibitors, experimental controls and buffers and dyes. It provides services such as customized solutions, proteomics services and custom antibody conjugation. CST offers research programs on pathway research, PTM data base, cancer research, protein kinases and cellular landscapes. The company has its presence in the Austria, Belgium, Germany, Netherlands, China and Japan. CST is headquartered in Danvers, Massachusetts, the US. Key subsidiaries of Cell Signaling Technology include CST (Shanghai) Biological Reagents, Cell Signaling Technology Japan and Cell Signaling Technology Europe.
The key metrics of Cell Signaling Technology related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Cell Signaling Technology is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Cell Signaling Technology.
For a detailed understanding of the performance of Cell Signaling Technology, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
